Jan. 25 2024
Source Page: DHSC annual report and accounts: 2022 to 2023Found: colleagues in MHRA to deliver stronger regulatory measures to reduce the number of pregnancies exposed to sodium
Written Evidence Jan. 24 2024
Committee: Health and Social Care Committee (Department: Department of Health and Social Care)Found: July 2 020. 10.The IMMDS Review explored issues relating to the use of hormone pregnancy tests, sodium
Asked by: Baroness Ritchie of Downpatrick (Labour - Life peer)
Question to the Department of Health and Social Care:
To ask His Majesty's Government, further to the Independent Medicines and Medical Devices Safety Review report First Do No Harm, published on 8 July 2020, what discussions they have had regarding the provision of monetary compensation for people adversely affected by clinical and surgical pelvic mesh.
Answered by Lord Markham - Parliamentary Under-Secretary (Department of Health and Social Care)
The Government has asked the Patient Safety Commissioner, Dr Henrietta Hughes, to undertake work looking at redress for people harmed by pelvic mesh and sodium valproate. The work is intended to focus on the views of those affected, improving the understanding of how many people have been affected and how, the case for redress and what form it could take.
The Patient Safety Commissioner office has stated that the report setting out the findings from this work is expected to be published on 7 February this year. The Government will consider the report’s findings before deciding how to proceed on this matter.
The Government published its response to the Independent Medicines and Medical Devices Safety review in July 2021, which did not accept the recommendation to establish a redress agency, this position remains unchanged.
Asked by: Baroness Ritchie of Downpatrick (Labour - Life peer)
Question to the Department of Health and Social Care:
To ask His Majesty's Government what recent assessment they have made of the recommendation for an Independent Redress Agency in the Independent Medicines and Medical Devices Safety Review report First Do No Harm, published on 8 July 2020.
Answered by Lord Markham - Parliamentary Under-Secretary (Department of Health and Social Care)
The Government has asked the Patient Safety Commissioner, Dr Henrietta Hughes, to undertake work looking at redress for people harmed by pelvic mesh and sodium valproate. The work is intended to focus on the views of those affected, improving the understanding of how many people have been affected and how, the case for redress and what form it could take.
The Patient Safety Commissioner office has stated that the report setting out the findings from this work is expected to be published on 7 February this year. The Government will consider the report’s findings before deciding how to proceed on this matter.
The Government published its response to the Independent Medicines and Medical Devices Safety review in July 2021, which did not accept the recommendation to establish a redress agency, this position remains unchanged.
Jan. 17 2024
Source Page: Freedom of Information responses from the MHRA - week commencing 28 November 2022Found: PL 29831/0 188 SODIUM VALPROATE WOCKHARDT 40MG/ML ORAL SOLUTIO N (SUGAR FREE) GRAN TED PL 29831
Jan. 17 2024
Source Page: Freedom of Information responses from the MHRA - week commencing 29 August 2022Found: Summary of mode of action: Zonisamide is an antagonist of voltage -dependent sodium and calcium channels
Mentions:
1: Alex Norris (LAB - Nottingham North) come through and find their moment, for whatever reason—whether they relate to Hillsborough, Primodos, sodium - Speech Link
Dec. 13 2023
Source Page: National Advisory Committee for Neurological Conditions minutes: February 2023Found: with the updated Medicines and Healthcare products Regulatory Agency (MHRA) guidance on the use of sodium
Correspondence Dec. 05 2023
Committee: Health and Social Care Committee (Department: Department of Health and Social Care)Found: families raise concerns about the safety of treatments , specifically looking into cases of pelvic mesh , sodium
Correspondence Nov. 29 2023
Committee: Health and Social Care Committee (Department: Department of Health and Social Care)Found: Correspondence from Patient Safety Commissioner to the Chair on Sodium valproate 16.11.23 Correspondence